HTG Molecular Diagnostics to Announce First Quarter 2020 Financial Results and Host Conference Call on Wednesday, May 13
May 11, 2020 16:01 ET
|
HTG Molecular Diagnostics, Inc.
TUCSON, Ariz., May 11, 2020 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM), a diagnostic company whose mission is to advance precision medicine, today announced that it will...
HTG Molecular Diagnostics Reports Full Year 2019 Results
March 25, 2020 16:01 ET
|
HTG Molecular Diagnostics, Inc.
Increased product and product-related services revenue over prior year, benefitting from expanded menu of profiling assays and increased number of customers adopting technology Released new...
HTG Molecular Diagnostics to Announce Year End 2019 Financial Results and Host Conference Call on Wednesday, March 25
March 17, 2020 08:00 ET
|
HTG Molecular Diagnostics, Inc.
TUCSON, Ariz., March 17, 2020 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM), a diagnostic company whose mission is to advance precision medicine, today announced that it will...
HTG Molecular to Present Corporate Overview at the SVB Leerink 9th Annual Global Healthcare Conference
February 19, 2020 08:00 ET
|
HTG Molecular Diagnostics, Inc.
TUCSON, Ariz., Feb. 19, 2020 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced that...
HTG EdgeSeq Mouse mRNA Tumor Response Panel Used by Researchers Targeting Cardiac Fibrosis with Engineered T-cells
February 11, 2020 08:00 ET
|
HTG Molecular Diagnostics, Inc.
TUCSON, Ariz., Feb. 11, 2020 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today highlighted the...
HTG EdgeSeq miRNA Whole Transcriptome Assay is Highly Reproducible in Biofluids for Potential Use as a Biomarker
February 05, 2020 08:00 ET
|
HTG Molecular Diagnostics, Inc.
TUCSON, Ariz., Feb. 05, 2020 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today highlighted the...
HTG Molecular Diagnostics Receives European Patent Grant Notification for Methods for Subtyping Diffuse Large B-cell Lymphoma
January 28, 2020 08:00 ET
|
HTG Molecular Diagnostics, Inc.
TUCSON, Ariz., Jan. 28, 2020 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced it has...
HTG Molecular Diagnostics Announces Preliminary 2019 Unaudited Financial Results
January 13, 2020 08:00 ET
|
HTG Molecular Diagnostics, Inc.
Preliminary full year 2019 unaudited revenue of $19.2 million Cash and cash equivalents of $33.0 million as of December 31, 2019 TUCSON, Ariz., Jan. 13, 2020 (GLOBE NEWSWIRE) -- HTG Molecular...
HTG Molecular Diagnostics to Host Key Opinion Leader Meeting on the Future of Precision Medicine
December 03, 2019 08:00 ET
|
HTG Molecular Diagnostics, Inc.
TUCSON, Ariz., Dec. 03, 2019 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced that it...
HTG Molecular Diagnostics Expands Analytics Capabilities with Release of New Software Update
November 19, 2019 08:00 ET
|
HTG Molecular Diagnostics, Inc.
TUCSON, Ariz., Nov. 19, 2019 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, yesterday announced the...